Alpha Teknova, Inc. (TKNO) stock
TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30125% above fair value
$7.77−0.44 (-5.36%)
Close on Nov 16, 2026Market cap $417.16MP/E –Yield –
Alpha Teknova pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Alpha Teknova's pe ratio was 40.7× on Jul 30, 2021.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Jul 30, 2021 | 40.7× | – |
See a number that looks wrong?